BioMoti is awarded a £150,000 TSB Biomedical Catalyst grant

BioMoti is among the first SME recipients of the new £180 million Technology Strategy Board (TSB) Biomedical Catalyst funding programme. The scheme was set-up by the UK government earlier this year to provide responsive and effective support for the best life science opportunities arising in the UK. BioMoti will use this first TSB award to […]

Read more